http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ac1b9edb4a5ce10b5ebbbc14cbaa2f5c
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Teh Tean Teh |
| name | Bin Tean Teh |
| given-name | Bin Tean Bin |
| organization-name | Laboratory of Cancer Epigenome National Cancer Centre Singapore Singapore; Cancer and Stem Cell Biology Duke‐NUS Medical School Singapore Laboratory of Cancer Epigenome, National Cancer Centre Singapore, Singapore, Singapore Program in Cancer and Stem Cell Biology, Duke-NUS Graduate Medical School, Singapore, Singapore Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore. Laboratory of Cancer Epigenome, National Cancer Centre SingaporeSingapore; Program in Cancer and Stem Cell Biology, Duke-NUS Medical SchoolSingapore, Singapore; Cancer Science Institute of Singapore, National University of SingaporeSingapore, Singapore; Institute of Molecular and Cell Biology, ASTARSingapore, Singapore. National Cancer Centre Singapore, Singapore. National Cancer Centre, Duke Graduate Medical School, Cancer Science Institute of Singapore, Institute of Molecular and Cellular Biology, Singapore 138673, Singapore Cancer and Stem Cell Biology Program, Duke–National University of Singapore Medical School, Singapore 169857, Singapore; Laboratory of Cancer Epigenome, Division of Medical Sciences, National Cancer Centre Singapore, Singapore 169610, Singapore 2Cancer and Stem Cell Biology, Duke-NUS Medical School, Singapore.; 3SingleHealth/Duke-NUS Institute of Precision Medicine, National Heart Center Singapore, Singapore.; 4Laboratory of Cancer Epigenome, Division of Medical Sciences, National Cancer Centre Singapore, Singapore.; 5Institute of Molecular and Cell Biology, Singapore. Laboratory of Cancer Genetics and Bioinformatics Program, Van Andel Research Institute, Grand Rapids, Michigan 2Cancer Genetics, and Duke-NUS Medical School, Singapore Cancer and Stem Cell Biology Program Duke‐NUS Medical School Singapore; Laboratory of Cancer Epigenome Division of Medical Sciences National Cancer Centre Singapore Singapore Division of Medical Sciences, National Cancer Centre Singapore, Singapore, Republic of Singapore Division of Cancer and Stem Cell Biology, Duke-NUS Graduate Medical School, Singapore, Republic of Singapore minhan.tan@gmail.com teh.bin.tean@singhealth.com.sg. Cancer and Stem Cell Biology Program, Duke-NUS Graduate Medical School, 8 College Road, Singapore 169857, Singapore.; National Cancer Centre Singapore–Van Andel Research Institute Translational Research Laboratory, Department of Medical Sciences, National Cancer Centre, 11 Hospital Drive, Singapore 169610, Singapore.; Laboratory of Cancer Genetics, Van Andel Research Institute, Grand Rapids, MI 49503, USA. Departments of Molecular Medicine Endocrine Tumor Unit (F.F., S.K., B.T.T., F.K.W., C.L.), SE-171 76 Stockholm, Sweden Department of Molecular Medicine, Endocrine Tumor Unit (F.F., B.T.T., A.S., C.P., C.L.), S-171 76 Stockholm, Sweden 5Laboratory of Cancer Genetics and 1Cancer and Stem Cell Biology Program, Duke-NUS Medical School, Singapore, Singapore.; 10Division of Medical Science, Laboratory of Cancer Epigenome, National Cancer Center, Singapore, Singapore.; 11Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.; 17SingHealth/Duke-NUS Institute of Precision Medicine, National Heart Centre, Singapore, Singapore. Laboratory of Cancer Epigenome, Division of Medical Science, National Cancer Centre Singapore, Singapore; Program in Cancer and Stem Cell Biology, Duke-NUS Medical School, Singapore; SingHealth/Duke-NUS Institute of Precision Medicine, National Heart Centre, Singapore; Cancer Science Institute of Singapore, National University of Singapore, Singapore; Genome Institute of Singapore, Singapore Division of Medical Oncology, National Cancer Centre Singapore, Singapore; SingHealth/Duke-NUS Institute of Precision Medicine, National Heart Centre Singapore, Singapore; Institute of Molecular and Cell Biology, A∗STAR Research Entities, Singapore 138673, Singapore. National Cancer Center and Duke-NUS Graduate Medical School, Singapore 169610 Van Andel Research Institute, Grand Rapids, MI 49503; and 1Laboratory of Cancer Genetics, and Laboratory of Cancer Epigenome National Cancer Centre Singapore Department of Molecular Medicine Karolinska Hospital CMM L8:01 Stockholm SE‐171 76 Sweden; Laboratory of Cancer Genetics Van Andel Research Institute 333 Bostic NE Grand Rapids Michigan 49503 USA Molecular Medicine (M.K., L.R., B.T., C.L.), S-171 76 Stockholm, Sweden 1Program in Cancer and Stem Cell Biology, Duke-NUS Medical School, Singapore.; 2Laboratory of Cancer Epigenome, Division of Medical Science, National Cancer Centre Singapore, Singapore.; 10Cancer Science Institute of Singapore, National University of Singapore, Singapore.; 34SingHealth/Duke-NUS Institute of Precision Medicine, National Heart Centre, Singapore.; 36Institute of Molecular and Cell Biology, Singapore. Laboratories of 1Cancer Genetics, 2Computational Biology, 3Molecular Epidemiology, 4Analytical, Cellular, and Molecular Microscopy, and 5Cell Signaling and Carcinogenesis and 6Division of Quantitative Sciences, Van Andel Research Institute; 7Department of Urology, Spectrum Health Hospital, Grand Rapids, Michigan; 8State Key Laboratory of Oncology in Southern China, Sun Yat-sen University Cancer Center, Guangzhou, China; 9Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands; 10Service d'Anatomie Pathologique, Hôpital d'Instruction des Armées Val de Grâce; 11Service d'Anatomie Pathologique, CHU Pitié Salpétrière; 12Service d'Anatomie Pathologique, CHU Ternon; 13Service d'Anatomie Pathologique, Hopital Saint Joseph; 14Service d'Anatomie Pathologique, CHU Cochin, Paris, France; 15Service d'Anatomie Pathologique, Hopital Foch, Suresnes, France; and 16Genomic Medicine Institute, Lerner Research Institute and Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio Laboratory of Cancer Therapeutics Program in Cancer and Stem Cell Biology Duke‐NUS Medical School Singapore City 169857 Singapore; Division of Medical Science Laboratory of Cancer Epigenome National Cancer Centre Singapore Singapore City 119074 Singapore 1Laboratory of Cancer Genetics, Van Andel Research Institute, Grand Rapids, Michigan; Cancer and Stem Cell Biology Programme, Duke-NUS Medical School, Singapore 169857, Singapore; Genome Institute of Singapore, Agency for Science, Technology and Research (A*STAR), Singapore 138672, Singapore; Laboratory of Cancer Epigenome, Division of Medical Science, National Cancer Center Singapore, Singapore 168583, Singapore; Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore 138673, Singapore Authors' Affiliations: 1State Key Laboratory of Oncology in South China, Departments of 2Pathology and 3Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong; 4Division of Pharmacoproteomics, Institute of Pharmacy and Pharmacology, University of South China, Hengyang, Hunan, China; 5NCCS-VARI Translational Research Program, 6Department of Surgical Oncology, and 7Division of Medical Sciences, National Cancer Center Singapore; 8Department of General Surgery, Singapore General Hospital, Singapore; 9Laboratories of Cancer Genetics and 10Genome Biology, Van Andel Research Institute (VARI), Grand Rapids, Michigan; and 11Center for Systems and Computational Biology, The Wistar Institute, Philadelphia, Pennsylvania; Authors' Affiliations: 1State Key Laboratory of Oncology in South China, Departments of 2Pathology and 3Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong; 4Division of Pharmacoproteomics, Institute of Pharmacy and Pharmacology, University of South China, Hengyang, Hunan, China; 5NCCS-VARI Translational Research Program, 6Department of Surgical Oncology, and 7Division of Medical Sciences, National Cancer Center Singapore; 8Department of General Surgery, Singapore General Hospital, Singapore; 9Laboratories of Cancer Genetics and 10Genome Biology, Van Andel Research Institute (VARI), Grand Rapids, Michigan; and 11Center for Systems and Computational Biology, The Wistar Institute, Philadelphia, Pennsylvania 16Van Andel Research Institute, Laboratory of Cancer Genetics, Grand Rapids, Michigan; and Laboratory of Cancer Genetics 1Cancer Genetics, Laboratories of Laboratory of Cancer Genetics, Van Andel Research Institute, Grand Rapids, MI.; NCCS-VARI Translational Cancer Research Laboratory, National Cancer Centre, Singapore. Institute of Molecular and Cell Biology, Singapore; Program in Cancer and Stem Cell Biology, Duke-NUS Medical School, Singapore; Laboratory of Cancer Epigenome, Division of Medical Sciences, National Cancer Centre Singapore, Singapore; Cancer Science Institute of Singapore, National University of Singapore, Singapore Laboratory of Cancer Epigenome, Division of Medical Sciences National Cancer Centre Singapore Singapore; Cancer Science Institute of Singapore National University of Singapore Singapore City Singapore; Programme in Cancer and Stem Cell Biology Duke‐NUS Medical School Singapore City Singapore 1Laboratories of Cancer Genetics, Authors' Affiliations: 1Department of Pharmacology and Toxicology and 2IU Simon Cancer Center, Indiana University School of Medicine, Indianapolis, Indiana; 3State Key Laboratory of Oncology in South China and 4Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China; 5Laboratories of Microarray Technology, and 6Cancer Genetics, Van Andel Research Institute, Grand Rapids, Michigan; and 7NCCS-VARI Translational Research Laboratory, National Cancer Center Singapore, Singapore; Authors' Affiliations: 1Department of Pharmacology and Toxicology and 2IU Simon Cancer Center, Indiana University School of Medicine, Indianapolis, Indiana; 3State Key Laboratory of Oncology in South China and 4Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China; 5Laboratories of Microarray Technology, and 6Cancer Genetics, Van Andel Research Institute, Grand Rapids, Michigan; and 7NCCS-VARI Translational Research Laboratory, National Cancer Center Singapore, Singapore Division of Medical Sciences, National Cancer Centre, Singapore, Singapore. 3Cancer and Stem Cell Biology Program, Duke-NUS Medical School, Singapore.; 6Cancer Science Institute of Singapore, National University of Singapore, Singapore.; 7Laboratory of Cancer Epigenome, Department of Medical Sciences, National Cancer Centre, Singapore.; 18SingHealth/Duke-NUS Institute of Precision Medicine, National Heart Centre Singapore, Singapore. Laboratory of Cancer Epigenome, National Cancer Centre Singapore Singapore Singapore Authors' Affiliations: 1Laboratory of Cancer Genetics and 2Laboratory of Analytical, Cellular, and Molecular Microscopy, Van Andel Research Institute, Grand Rapids, Michigan and 3The State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China Department of Molecular Medicine Endocrine Tumor Unit, CMM L8:01 Karolinska Hospital SE‐171 76 Stockholm Sweden Laboratory of Cancer Epigenome, National Cancer Centre, Singapore, Singapore; Duke-NUS Graduate Medical School, Singapore, Singapore 2Institute of Molecular and Cell Biology, Singapore.; 3Laboratory of Cancer Epigenome, Department of Medical Sciences, National Cancer Centre, Singapore.; 5Cancer and Stem Cell Biology Program, Duke-NUS Medical School, Singapore.; 8Cancer Science Institute of Singapore, National University of Singapore, Singapore.; 17SingHealth/Duke-NUS Institute of Precision Medicine, National Heart Centre Singapore, Singapore. Authors' Affiliations: 1Laboratory of Cancer Genetics, 2Laboratory of Computational Biology, Van Andel Research Institute, Grand Rapids, Michigan; Departments of 3Anatomic Pathology and 4Solid Tumor Oncology and Urology, Cleveland Clinic, Cleveland, Ohio; 5The State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Guangzhou, People's Republic of China; 6Department of Urology, Spectrum Health, Grand Rapids, Michigan; and 7Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, United Kingdom Laboratory of Cancer Epigenome National Cancer Centre Singapore Singapore Laboratory of Cancer Genetics, Van Andel Research Institute, Grand Rapids, Michigan Authors' Affiliations: 1Cellular and Molecular Research, National Cancer Centre, 2Cancer and Stem Cell Biology Program, Duke-NUS Graduate Medical School, 3NCCS-VARI Translational Cancer Research Laboratory, National Cancer Centre, 4Neuroscience and Behavioral Disorders, Duke-NUS Graduate Medical School, 5Laboratory of Computational Biology, Van Andel Research Institute, Michigan, 6Department of Physiology, National University of Singapore 7Nanyang Technological University, and 8Singapore-MIT Alliance, Singapore; 9Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, and 10Section of Pathology and Tumour Biology, Leeds Institute of Molecular Medicine, St James's University Hospital, Leeds, United Kingdom; 11Laboratory of Cancer Genetics, Van Andel Research Institute, Grand Rapids, Michigan; 12Cancer Science Institute of Singapore, Yong Loo Lin School of Medicine, National University of Singapore, and 13Genome Institute of Singapore, Singapore; Authors' Affiliations: 1Cellular and Molecular Research, National Cancer Centre, 2Cancer and Stem Cell Biology Program, Duke-NUS Graduate Medical School, 3NCCS-VARI Translational Cancer Research Laboratory, National Cancer Centre, 4Neuroscience and Behavioral Disorders, Duke-NUS Graduate Medical School, 5Laboratory of Computational Biology, Van Andel Research Institute, Michigan, 6Department of Physiology, National University of Singapore 7Nanyang Technological University, and 8Singapore-MIT Alliance, Singapore; 9Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, and 10Section of Pathology and Tumour Biology, Leeds Institute of Molecular Medicine, St James's University Hospital, Leeds, United Kingdom; 11Laboratory of Cancer Genetics, Van Andel Research Institute, Grand Rapids, Michigan; 12Cancer Science Institute of Singapore, Yong Loo Lin School of Medicine, National University of Singapore, and 13Genome Institute of Singapore, Singapore Authors' Affiliations: Laboratories of 1Cancer Genetics, 2Cytogenetics, and 3Computational Biology, Van Andel Research Institute; 4Department of Urology, Spectrum Health Hospital, Grand Rapids, Michigan; and 5NCCS-VARI Translational Research Laboratory, National Cancer Centre Singapore, Singapore; Authors' Affiliations: Laboratories of 1Cancer Genetics, 2Cytogenetics, and 3Computational Biology, Van Andel Research Institute; 4Department of Urology, Spectrum Health Hospital, Grand Rapids, Michigan; and 5NCCS-VARI Translational Research Laboratory, National Cancer Centre Singapore, Singapore Laboratories of Cancer Genetics, DNA and Protein Microarray Technology, and Molecular Oncology, Van Andel Research Institute, Grand Rapids, MI 49503; and Department of Urology, School of Medicine, The University of Tokushima, Tokushima 770-8503, Japan National Cancer Centre Singapore–Van Andel Research Institute Translational Cancer Research Laboratory, National Cancer Centre Singapore, Singapore; and Laboratory of Cancer Genetics, Van Andel Research Institute, Grand Rapids, MI Authors' Affiliation: 1NCCS-VARI Translational Research Laboratory, Department of Medical Sciences, 2Division of Clinical Trials and Epidemiological Sciences, Departments of 3Medical Oncology and 4Radiation Oncology, National Cancer Centre Singapore; Departments of 5Pathology, 6Hematology, and 7Ear, Nose and Throat, Singapore General Hospital; 8Neuroscience and Behavioral Disorders, 9Cancer and Stem Cell Biology Program, 10Duke-NUS Graduate Medical School Singapore, 11Cancer Science Institute of Singapore, NUS, and 12Genome Institute of Singapore, Singapore; Authors' Affiliation: 1NCCS-VARI Translational Research Laboratory, Department of Medical Sciences, 2Division of Clinical Trials and Epidemiological Sciences, Departments of 3Medical Oncology and 4Radiation Oncology, National Cancer Centre Singapore; Departments of 5Pathology, 6Hematology, and 7Ear, Nose and Throat, Singapore General Hospital; 8Neuroscience and Behavioral Disorders, 9Cancer and Stem Cell Biology Program, 10Duke-NUS Graduate Medical School Singapore, 11Cancer Science Institute of Singapore, NUS, and 12Genome Institute of Singapore, Singapore Laboratory of Cancer Therapeutics, Program in Cancer and Stem Cell Biology Duke‐NUS Medical School Singapore City Singapore; Institute of Molecular and Cell Biology Agency for Science Technology and Research Singapore City Singapore; Division of Medical Science, Laboratory of Cancer Epigenome National Cancer Centre Singapore Singapore City Singapore VanAndel Research Institute (B.T.T.), Grand Rapids, Michigan 49503 Laboratory of Cancer Epigenome, Division of Medical Sciences, National Cancer Centre, Singapore, Singapore Division of Cancer and Stem Cell Biology, Duke-NUS Graduate Medical School, Singapore, Singapore Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore. National Cancer Centre Singapore, Singapore Laboratory of Cancer Genetics (S.K.K., B.T.T., D.C.L.-C.), Van Andel Research Institute, Grand Rapids, Michigan 49503 1Laboratory of Cancer Genetics,; 5NCCS-VARI Translational Research Laboratory, National Cancer Center, Singapore, Singapore NCCS-VARI Translational Cancer Research Laboratory, National Cancer Centre, 169610, Singapore 1Laboratory of Cancer Genetics, Laboratory of Cancer Epigenome National Cancer Centre Singapore Singapore City Singapore; Program in Cancer and Stem Cell Biology Duke‐NUS Medical School Singapore City Singapore; Institute of Molecular and Cell Biology Singapore City Singapore; Cancer Science Institute of Singapore National University of Singapore Singapore City Singapore; Oncology Academic Clinical Program Duke‐NUS Medical School Singapore City Singapore Laboratory of Cancer Epigenome National Cancer Centre Singapore Singapore Singapore; Laboratory of Biodiversity Genomics Genome Institute of Singapore Singapore Singapore; Programme in Cancer and Stem Cell Biology Duke‐NUS Medical School Singapore Singapore; Institute of Molecular and Cellular Biology ASTAR Singapore Singapore; Oncology Academic Clinical Program Duke‐NUS Medical School Singapore Singapore NCCS-VARI Translational Research Laboratory, Division of Medical Sciences, National Cancer Centre Singapore, 11 Hospital Drive, Singapore 169610, Singapore.; Program in Cancer and Stem Cell Biology, Duke-NUS Graduate Medical School, 8 College Road, Singapore 169857, Singapore.; Cancer Science Institute of Singapore, National University of Singapore, Centre for Life Sciences, 28 Medical Drive, Singapore 117456, Singapore. |
Incoming Links
Total number of triples: 359.